Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Brand-name prescription medicine

Licart

Generic name: Diclofenac epolamine

FDA application holder: Ibsa Inst Bio

Strengths and generic versions Official label

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

1Strengths and forms
13Same medicine, other names
2018FDA approval
0Recalls (FDA reports)

Quick answers

What is Licart?
Licart is a brand name of Diclofenac epolamine, a prescription medicine. The FDA NDC Directory lists 2 Licart products in 1 strength and form.
Who makes Licart?
Ibsa Inst Bio holds the FDA application for Licart (NDA206976, approved December 19, 2018). 1 other company (repackagers or distributors) also list Licart products.
Is there a generic or store brand of Licart?
Yes. The FDA NDC Directory lists 13 other products with the same active ingredients, strength and form as a Licart product, 12 of them generic. Ask your pharmacist whether one is right for you.
Has Licart been recalled?
No recall linked to Licart products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Licart is

Each Licart product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Diclofenac epolamine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
diclofenac epolamine 0.013 g
system (topical)		 Licart 13 products, 12 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Diclofenac epolamine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Licart products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA206976Ibsa Inst BioDecember 19, 20182

Companies that list Licart

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Licart products.

Recalls

No recall linked to Licart products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers